Nuveen’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Nuveen’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$158K	Buy	+1,547	New	+$159K	﹤0.01%	3868

Other funds holding IHE

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return

McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return

Arkansas Financial Group Little Rock, Arkansas $751M AUM 9.21% 1-Year Est. Return

Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return

Nuveen's IHE Position: Q3 2026 in Review

Nuveen opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 1,547 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #3868 among its holdings.

152 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

Nuveen held 1,547 shares of iShares US Pharmaceuticals ETF worth $158K as of Q3 2026.
iShares US Pharmaceuticals ETF was a new Nuveen position in Q3 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #3868 holding.
152 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.